Industry watchers are predicting good things for J&J’s experimental psoriasis drug ustekinumab. (Sorry about the hard-to-say generic name; we haven’t yet heard what the brand name is.) The drug will be vetted tomorrow by a panel of FDA advisers, and the briefing documents for the meeting were published online late last week.
Studies show the drug [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment